Mission
Based on extensive research in carbohydrate polymers and iron carbohydrate complexes, Pharmacosmos persistently develops and markets pharmaceuticals for intravenous iron injection and total dose iron infusion therapy.
Pharmacosmos strives to be the preferred Dextran supplier with respect to product quality, purity, safety and efficacy. As an important part of our business development, Pharmacosmos participates in leading research activities, which may identify novel applications of Dextran and other carbohydrate polymers.
Veterinary Iron Dextran injection for prevention of piglet iron deficiency anemia constitutes an important part of our activities. Pharmacosmos will continuously engage in scientific studies to further substantiate the effects of Uniferon® Iron Dextran as iron supplement in piglets.
On the basis of extensive knowledge about carbohydrate and iron carbohydrate chemistry, Pharmacosmos develops the new generation of drug products for intravenous iron infusion used in treatment of iron deficiency anemia.